Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Financing repurposed drugs for rare diseases: a case study of Unravel Biosciences

Fig. 1

Summary of results (a) and sensitivity analysis (b) for the Rett syndrome compound. In panel (a), actual NPVs obtained by running 10,000 Monte Carlo simulation paths in ModelRisk using base-case parameters. In panel (b), blue highlighting indicates the base-case parameters, and heat-map coloring indicates the impact on the estimated rNPV (with lower values colored in red and higher values colored in green)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172